Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.

Cuesta JG, Aavitsland P, Englund H, Gudlaugsson Ó, Hauge SH, Lyytikäinen O, Sigmundsdóttir G, Tegnell A, Virtanen M; Nordic influenza comparison group, Krause TG.

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30208.

PMID:
27123691
2.

Screening for Mycoplasma genitalium infection?

Aavitsland P.

Tidsskr Nor Laegeforen. 2016 Jan 26;136(2):104. doi: 10.4045/tidsskr.16.0038. eCollection 2016 Jan 26. English, Norwegian. No abstract available.

3.

The quality of denominator data in surgical site infection surveillance versus administrative data in Norway 2005-2010.

Løwer HL, Eriksen HM, Aavitsland P, Skjeldestad FE.

BMC Infect Dis. 2015 Nov 30;15:549. doi: 10.1186/s12879-015-1289-x.

4.

Denominators count: supplementing surveillance data for genital Chlamydia trachomatis infection with testing data, Norway, 2007 to 2013.

Kløvstad H, Aavitsland P.

Euro Surveill. 2015;20(36). doi: 10.2807/1560-7917.ES.2015.20.36.30012.

PMID:
26535784
5.

Response to letter to the editor regarding: "Surgical site infections after hip arthroplasty in Norway, 2005-2011: Influence of duration and intensity of postdischarge surveillance".

Løwer HL, Dale H, Eriksen HM, Aavitsland P, Skjeldestad FE.

Am J Infect Control. 2015 Sep 1;43(9):1024-5. doi: 10.1016/j.ajic.2015.06.011. Epub 2015 Jul 29. No abstract available.

PMID:
26231546
6.

Surgical site infections after hip arthroplasty in Norway, 2005-2011: influence of duration and intensity of postdischarge surveillance.

Løwer HL, Dale H, Eriksen HM, Aavitsland P, Skjeldestad FE.

Am J Infect Control. 2015 Apr 1;43(4):323-8. doi: 10.1016/j.ajic.2014.12.013. Epub 2015 Feb 8.

PMID:
25672951
7.
8.

[Scientificity and justifiability].

Aavitsland P, Berild D, Emmert A, Horn M, Rørtveit G.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):138-9. doi: 10.4045/tidsskr.13.1682. Norwegian. No abstract available.

9.

Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality.

Gran JM, Kacelnik O, Grjibovski AM, Aavitsland P, Iversen BG.

Influenza Other Respir Viruses. 2013 Nov;7(6):1370-9. doi: 10.1111/irv.12125. Epub 2013 Jun 8.

10.

Trends in HIV infection surveillance data among men who have sex with men in Norway, 1995-2011.

Jakopanec I, Grjibovski AM, Nilsen Ø, Blystad H, Aavitsland P.

BMC Public Health. 2013 Feb 17;13:144. doi: 10.1186/1471-2458-13-144.

11.
12.

Risk of fetal death after pandemic influenza virus infection or vaccination.

Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I, Furu K, Nafstad P, Vollset SE, Feiring B, Nøkleby H, Magnus P, Stoltenberg C.

N Engl J Med. 2013 Jan 24;368(4):333-40. doi: 10.1056/NEJMoa1207210. Epub 2013 Jan 16.

13.

Methodology of the Norwegian Surveillance System for Healthcare-Associated Infections: the value of a mandatory system, automated data collection, and active postdischarge surveillance.

Løwer HL, Eriksen HM, Aavitsland P, Skjeldestad FE.

Am J Infect Control. 2013 Jul;41(7):591-6. doi: 10.1016/j.ajic.2012.09.005. Epub 2013 Jan 11.

PMID:
23318091
14.

Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: a cross sectional study.

Kløvstad H, Grjibovski A, Aavitsland P.

BMC Infect Dis. 2012 Jul 2;12:150. doi: 10.1186/1471-2334-12-150.

15.

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.

Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K.

BMC Infect Dis. 2012 Mar 20;12:63. doi: 10.1186/1471-2334-12-63.

16.

Evaluation of the national surveillance system for point-prevalence of healthcare-associated infections in hospitals and in long-term care facilities for elderly in Norway, 2002-2008.

Hajdu A, Eriksen HM, Sorknes NK, Hauge SH, Loewer HL, Iversen BG, Aavitsland P.

BMC Public Health. 2011 Dec 13;11:923. doi: 10.1186/1471-2458-11-923.

17.

Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010.

Elstrøm P, Kacelnik O, Bruun T, Iversen B, Hauge SH, Aavitsland P.

J Hosp Infect. 2012 Jan;80(1):36-40. doi: 10.1016/j.jhin.2011.10.004. Epub 2011 Nov 25.

PMID:
22118858
18.

Salmonellosis and charter tourism: epidemiology and trends of imported human cases to Norway from the Canary Islands and Thailand, 1994-2008.

Emberland KE, Nygård K, Aavitsland P.

Epidemiol Infect. 2012 Sep;140(9):1655-62. doi: 10.1017/S0950268811002123. Epub 2011 Nov 4.

PMID:
22051449
19.

Detection of events of public health importance under the international health regulations: a toolkit to improve reporting of unusual events by frontline healthcare workers.

MacDonald E, Aavitsland P, Bitar D, Borgen K.

BMC Public Health. 2011 Sep 21;11:713. doi: 10.1186/1471-2458-11-713. Review.

20.

[The pandemic in Austevoll].

Aavitsland P, Iversen BG, Nøkleby H.

Tidsskr Nor Laegeforen. 2011 Jun 17;131(12):1180. doi: 10.4045/tidsskr.11.0524. Norwegian. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk